These 4 Marijuana Stocks Could Surpass Investor Expectations

CORAL GABLES, FL / ACCESSWIRE / February 4, 2019 / Marijuana stocks have managed to become one of the hottest topics in the news over the course of the past few years. The fact of the matter is that previously conceived notions on cannabis are being replaced by favorable public opinions supporting all possible uses of marijuana, namely as a means of treatment for patients suffering from a myriad of ailments. Following the recent passing of legislation in favor of legalizing cannabis, it is very likely that companies in the space will work even harder to develop innovative treatment options and products, designed with the consumer in mind. With the increase of capital and business entering the market, the cannabis sector has shown exciting promise in terms of opportunities for investors looking to space. Global Consortium Inc (GCGX), Emerald Health Therapeutics Inc (EMHTF) (EMH.V), Trulieve Cannabis Corp (OTC PINK: TCNNF), and OrganiGram Holdings Inc (OGRMF) are four pot stocks looking to remain on high this month.

Global Consortium Inc (GCGX) that you might not have heard of, but could definitely benefit from looking into. As the marijuana market has become increasingly more lucrative for some time now, Global Consortium is putting in the work to become one of the industry leaders in terms of hemp-derived CBD products. The company has maintained a focus that not only targets corporate growth but also tackles the public markets as well. Just before the end of the new year, the Company announced that it had rescinded their transactions with Trans Global Group, Inc. effective December 31, 2018.

As the Company takes the steps necessary to lead the CBD industry into the future, Global Consortium Inc (GCGX) has made it a point to build a corporate framework for these aspirations to be built upon. The Company today announced plans to design and build out America's first "Cannabis Mall." Per the details of the announcement, the Cannabis Mall, when completed, will house manufacturing, distribution, delivery, retail, and cultivation all under one 64,000 sure foot building.

Global Consortium Inc (GCGX) has stated that the distribution component of their "Cannabis Mall" will be leased out to a 3rd party with a 50% revenue share for Global, and all of Global's products will be distributed for free. The completion of the build out and final inspections are expected to be completed by April 1, 2019, at which time distribution will go operational.

For More Information On Global Consortium Inc, Click Here

Emerald Health Therapeutics Inc (EMHTF) (EMH) announced at the tail-end of last month that its joint venture partner, San Diego-based Emerald Health Bioceuticals, has launched its award-winning Endo products in Whole Foods Markets across the United States, highlighting the unique positioning and opportunity for this product line when it is launched in Canada in 2019. The joint venture, called Emerald Health Naturals, secured Canadian distribution rights for this product line that was developed to support the body's endocannabinoid system (ECS), but which does not contain cannabis. Canadian retailers have not been announced.

Gaetano Morello, CEO of Emerald Health, commented, "for the Endo products to be embraced by retailers with such high standards of retail excellence and broad reach like Whole Foods Market in the US is an important milestone for this unique natural health supplement line."

For More Information On Emerald Health Therapeutics Inc, Click Here

Trulieve Cannabis Corp (TCNNF) saw its shares enjoy a 6.10% boost in mid-afternoon trading on Monday, with shares trading at $12.53 per share. Towards the end of last month, the Company announced that it had been named the 2018 Diversity and Inclusion Champion of the Year by Minorities for Medical Marijuana. According to the announcement, the annual award acknowledges a leading cannabis organization for its leadership efforts in diversity and inclusion in two categories: Organizational Diversity and Inclusion and Market Outreach Strategies.

Following the announcement of the award, Kim Rivers, Trulieve's CEO, said, "we are incredibly honored to be the recipient of Minorities for Medical Marijuana's inaugural Diversity and Inclusion Champion of the Year Award."